CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM - CRINETICS PHARMACEUTICALS IN ownership

CRINETICS PHARMACEUTICALS IN's ticker is CRNX and the CUSIP is 22663K107. A total of 72 filers reported holding CRINETICS PHARMACEUTICALS IN in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM ownership history of CRINETICS PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$1,815,121
+97.8%
61,033
+19.8%
0.00%
+200.0%
Q2 2023$917,867
+8.5%
50,936
-3.3%
0.00%0.0%
Q1 2023$845,655
-13.9%
52,656
-1.9%
0.00%
-50.0%
Q4 2022$982,307
-5.6%
53,678
+1.3%
0.00%0.0%
Q3 2022$1,041,000
+2.8%
53,010
-2.4%
0.00%0.0%
Q2 2022$1,013,000
-4.6%
54,338
+12.3%
0.00%
+100.0%
Q1 2022$1,062,000
-28.6%
48,377
-7.7%
0.00%
-50.0%
Q4 2021$1,488,000
+82.8%
52,392
+35.6%
0.00%
+100.0%
Q3 2021$814,000
-14.2%
38,650
-23.2%
0.00%0.0%
Q2 2021$949,000
+52.3%
50,354
+23.4%
0.00%0.0%
Q1 2021$623,000
+8.2%
40,7980.0%0.00%0.0%
Q4 2020$576,000
-9.9%
40,7980.0%0.00%0.0%
Q3 2020$639,000
-10.6%
40,7980.0%0.00%0.0%
Q2 2020$715,000
+182.6%
40,798
+137.2%
0.00%0.0%
Q1 2020$253,000
-40.7%
17,197
+1.2%
0.00%0.0%
Q4 2019$427,000
+66.8%
17,0000.0%0.00%
Q3 2019$256,000
-39.8%
17,0000.0%0.00%
-100.0%
Q2 2019$425,000
+40.3%
17,000
+27.7%
0.00%0.0%
Q1 2019$303,000
-7.6%
13,309
+21.7%
0.00%0.0%
Q4 2018$328,000
+8.6%
10,932
+3.9%
0.00%0.0%
Q3 2018$302,00010,5260.00%
Other shareholders
CRINETICS PHARMACEUTICALS IN shareholders Q3 2020
NameSharesValueWeighting ↓
Saturn V Capital Management LP 623,819$11,336,5019.41%
Finepoint Capital LP 822,745$15,0564.87%
Bain Capital Life Sciences Investors, LLC 2,305,558$42,1924.72%
Opaleye Management Inc. 732,000$13,395,6004.66%
5AM Venture Management, LLC 862,286$15,779,8344.24%
SPHERA FUNDS MANAGEMENT LTD. 671,644$12,291,0852.64%
First Light Asset Management, LLC 1,329,313$24,326,4282.26%
BRAIDWELL LP 3,469,674$63,495,0342.13%
BVF INC/IL 2,736,613$50,080,0182.11%
Perceptive Advisors 4,039,276$73,918,7512.08%
View complete list of CRINETICS PHARMACEUTICALS IN shareholders